Atlas Trials

Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis

Clinical trial NCT01047072 · WITHDRAWN

Trial details

NCT number
NCT01047072
Sponsor
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Systemic Scleroderma
Primary completion
2017-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.